Denise Rezende: Werfen Reflects on a Successful ISTH 2026 Congress
Denise Rezende, Product Manager of Systems Worldwide Marketing, Hemostasis at Werfen North America, shared a post on LinkedIn:
“Every congress tells a story, and ISTH 2026 was a remarkable one.
After months of planning, countless meetings, long days, and navigating the unexpected, it was incredibly rewarding to see everything come together in Paris.
One of the highlights for me was seeing our Presentation Theater completely full.
Reconnecting with colleagues, customers, and friends from around the world, exchanging ideas, and discussing the future of thrombosis and hemostasis reminded me why events like ISTH are so important.
They go far beyond showcasing innovation—they create opportunities to learn from one another, strengthen partnerships, and work together toward better patient care.
A sincere thank you to the International Society on Thrombosis and Hemostasis (ISTH) for organizing another outstanding congress, and to everyone who visited the Werfen booth, attended our presentations, and took the time to connect with our team.
Every conversation, every question, and every new connection made this experience even more meaningful.
A special thank you to my amazing colleagues.
Behind every successful event is a dedicated team committed to delivering excellence, supporting one another, and finding solutions every step of the way.
Your professionalism, collaboration, and commitment made all the difference, and I feel incredibly grateful to have shared this journey with all of you.
As I leave Paris, I take with me new ideas, stronger partnerships, inspiring conversations, and memories that will stay with me for a long time.
Until next time… see you at ISTH 2027 in Vancouver!”
Stay updated with Hemostasis Today.
-
Aug 13, 2026, 11:15Bridging Neurology and Thrombosis: Key Priorities from a New Expert Consensus Report – International Journal of Stroke
-
Aug 13, 2026, 11:05Khaled Musallam: The Evolving Landscape of β-Thalassemia: Clinical Trial Advances Since 2021
-
Aug 13, 2026, 10:31Brad Wilson: Clinical Insights from the Landmark ESC 2026 Trials
-
Aug 13, 2026, 10:23Rania Baleela: Evaluating Bedside Diagnostics and VICC Outcomes in Hemotoxic Snakebite
-
Aug 13, 2026, 10:11Christina Kounoudi: Low-Dose vs. Therapeutic Anticoagulation in Extended VTE Prophylaxis
-
Aug 13, 2026, 10:10Jean Connors: Can Prothrombin Levels Improve Antiphospholipid Syndrome Risk Assessment?
-
Aug 13, 2026, 09:44Edward Lee Carter: Why Clinically Relevant Nonmajor Bleeding Demands Anticoagulation Stewardship?
-
Aug 13, 2026, 09:40Neel Bhut: Can AI Help Us Make Gene Therapy More Efficient?
-
Aug 13, 2026, 08:23Sally Mandour: The Diagnostic Challenge of Hypocellular Bone Marrow Failure